Breaking News Instant updates and real-time market news.

NVCR

Novocure

$8.25

-0.25 (-2.94%)

07:01
10/12/16
10/12
07:01
10/12/16
07:01

Novocure enrolls first patient in METIS phase 3 pivotal trial

Novocure announced that the first patient has been enrolled in the METIS trial, a phase 3 pivotal trial studying radiosurgery plus Tumor Treating Fields compared to radiosurgery alone for the treatment of brain metastases from non-small cell lung cancer, or NSCLC. METIS is Novocure's first phase 3 pivotal trial outside of glioblastoma.

NVCR Novocure
$8.25

-0.25 (-2.94%)

01/19/16
01/19/16
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ARIAD (ARIA) initiated with an Underweight at Barclays... Adamas Pharmaceuticals (ADMS) initiated with a Neutral at Mizuho... CSRA (CSRA) initiated with an Outperform at RBC Capital... Novocure (NVCR) initiated with an Underweight at Barclays... Pure Storage (PSTG) initiated with a Buy at Lake Street... Sphere 3D (ANY) initiated with a Buy at Ladenburg.
01/20/16
WELS
01/20/16
NO CHANGE
WELS
Novocure data encouraging, says Wells Fargo
Wels Fargo quotes consultants with whom it spoke as saying that the the progression free survival and overall survival data for Novocure's Phase 2 study of PANOVA significantly exceeded expectations. However, the consultants noted that the study was very small, consisting of only 20 patients. They added that the adverse effects of the drug came in above expectations, although the company said they were in-line with historical data. Wells is encouraged by the efficacy data and keeps an Outperform rating on the shares.
01/20/16
JMPS
01/20/16
NO CHANGE
JMPS
Novocure results 'remarkable,' says JMP Securities
JMP Securities believes that the 14.9 month mean overall survival rate demonstrated by Novocure's (NVCR) pancreatic cancer treatment is "remarkable." The firm notes that Celgene's (CELG) Abraxane obtained FDA approval after the overall survival rate of patients taking it increased to 8.5 months. The firm keeps a $43 price target and Outperform rating on NovoCure.
04/28/16
WELS
04/28/16
NO CHANGE
WELS
Novocure Optune data, outlook positive, says Wells Fargo
After speaking with a neuro-oncologist who is a high-volume prescriber of Novocure's Optune for glioblastoma, Wells Fargo says that the EV-14 pivotal data for the drug showed convincing efficacy levels and "very, very low risk." The firm expects the drug's penetration of newly diagnosed glioblastoma patients to increase. Wells thinks the stock has a number of potential positive catalysts this year, and it keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

AMD

AMD

$13.40

-0.68 (-4.83%)

, NVDA

Nvidia

$146.58

-5.57 (-3.66%)

08:25
06/28/17
06/28
08:25
06/28/17
08:25
Recommendations
AMD, Nvidia analyst commentary  »

Nvidia crypto-currency…

AMD

AMD

$13.40

-0.68 (-4.83%)

NVDA

Nvidia

$146.58

-5.57 (-3.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 29

    Aug

GEF

Greif

$53.95

-1.56 (-2.81%)

08:25
06/28/17
06/28
08:25
06/28/17
08:25
Conference/Events
Greif to host investor breakfast day »

Investor Breakfast Day to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MCK

McKesson

$166.69

-0.92 (-0.55%)

08:25
06/28/17
06/28
08:25
06/28/17
08:25
Conference/Events
McKesson to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 26

    Jul

  • 30

    Jul

KMPH

KemPharm

$3.45

0.05 (1.47%)

08:24
06/28/17
06/28
08:24
06/28/17
08:24
Initiation
KemPharm initiated  »

KemPharm initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$106.77

-1.58 (-1.46%)

08:22
06/28/17
06/28
08:22
06/28/17
08:22
Recommendations
ServiceNow analyst commentary  »

ServiceNow shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

08:20
06/28/17
06/28
08:20
06/28/17
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$220.28

-0.16 (-0.07%)

08:20
06/28/17
06/28
08:20
06/28/17
08:20
Recommendations
Goldman Sachs analyst commentary  »

Goldman Sachs price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 17

    Oct

$DJU

DJ Utility Average

08:20
06/28/17
06/28
08:20
06/28/17
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:20
06/28/17
06/28
08:20
06/28/17
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$168.95

-1.025697 (-0.60%)

08:20
06/28/17
06/28
08:20
06/28/17
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
06/28/17
06/28
08:20
06/28/17
08:20
General news
U.S. advance goods trade deficit preview: »

U.S. advance goods trade…

XLK

Technology Select Sector SPDR

$55.08

-0.92 (-1.64%)

08:19
06/28/17
06/28
08:19
06/28/17
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$64.14

-0.1 (-0.16%)

08:19
06/28/17
06/28
08:19
06/28/17
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$35.09

-0.91 (-2.53%)

08:19
06/28/17
06/28
08:19
06/28/17
08:19
Earnings
Chemours raises 2017 adjusted EBITDA view to 'above $1.25B' »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$89.13

-0.71 (-0.79%)

08:19
06/28/17
06/28
08:19
06/28/17
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$53.68

-0.33 (-0.61%)

08:19
06/28/17
06/28
08:19
06/28/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$52.97

-0.6 (-1.12%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$55.23

-0.48 (-0.86%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDXG

Interpace Diagnostics

$0.85

-0.043 (-4.82%)

, AET

Aetna

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Hot Stocks
Interpace Diagnostics announces national contract with Aetna »

Interpace Diagnostics…

IDXG

Interpace Diagnostics

$0.85

-0.043 (-4.82%)

AET

Aetna

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBIO

Catalyst Biosciences

$4.47

-0.07 (-1.54%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Hot Stocks
Catalyst granted orphan product designation for hemophilia B candidate in Europe »

Catalyst Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

XLV

Health Care Select Sector SPDR

$79.66

-0.73 (-0.91%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$139.84

-1.24 (-0.88%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$212.93

-0.94 (-0.44%)

08:17
06/28/17
06/28
08:17
06/28/17
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$241.33

-1.96 (-0.81%)

08:17
06/28/17
06/28
08:17
06/28/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$24.14

0.12 (0.50%)

08:17
06/28/17
06/28
08:17
06/28/17
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.